providing a platform: first results for liso-cel plus durvalumab in r/r b-cell nhl
Published 5 years ago • 116 plays • Length 3:23Download video MP4
Download video MP3
Similar videos
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
1:06
epcore nhl-1: two and a half year follow-up of epcoritamab in dlbcl
-
4:09
real-world safety and efficacy of liso-cel in r/r large b-cell lymphoma
-
3:59
3-year follow-up from the transform trial: liso-cel is superior to soc in r/r dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
2:18
a cost per responder analysis of cilta-cel vs physician's choice in lenalidomide-refractory mm
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:58
meet caroline: a childhood leukemia survivor
-
2:41
israeli company on the edge of finding diabetes cure
-
6:24
indiko biochemistry analyzer demonstration
-
3:34
transcend-cll-004: pivotal in the fda approval of liso-cel for r/r cll
-
4:32
following a lab sample from collection to diagnosis
-
6:48
electrolyte analyzer ⅰ installation guide
-
2:54
ck0804, a cord blood-derived cellular therapy, in myelofibrosis with suboptimal ruxolitinib response
-
1:34
recent and upcoming data on axi-cel for patients with nhl
-
0:45
difference between quality of life & patient-reported outcomes
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:48
healthcare costs associated with liso-cel in an inpatient versus outpatient setting for mcl
-
2:41
an overview of the latest advances in hematology
-
0:53
how to upload medical records for a medical chronology